Allergan to Buy Tobira Therapeutics in $1.7 Billion Deal Allergan to Buy Tobira Therapeutics in $1.7 Billion Deal : Allergan could pay up to 19 times the value of the liver-disease treatment maker. Allergan PLC on Tuesday said it agreed to acquire Tobira Therapeutics Inc., a biopharmaceutical company that develops […]